FasL on human nucleus pulposus cells prevents angiogenesis in the disc by inducing Fas-mediated apoptosis of vascular endothelial cells

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 11, 2013, Pages 2376-2385

  Sun, Zhen ^a   Wan, Zhong Yuan ^a   Guo, Yun Shan ^a   Wang, Hai Qiang ^a   Luo, Zhuo Jing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Fas; FasL; HMEC 1; Intervertebral disc; Nucleus pulposus; Vascular endothelial cells

Indexed keywords

CASP3 PROTEIN, HUMAN; CASPASE 3; FADD PROTEIN, HUMAN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; FAS PROTEIN, HUMAN; FASLG PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CELL CULTURE; COCULTURE; ENDOTHELIUM CELL; FAS; FASL; FEMALE; HMEC-1; HUMAN; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NUCLEUS PULPOSUS; PARACRINE SIGNALING; PATHOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL CELLS;

FAS; FASL; HMEC-1; INTERVERTEBRAL DISC; NUCLEUS PULPOSUS; VASCULAR ENDOTHELIAL CELLS;

ADULT; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; HUMANS; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION;

EID: 84887075789     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Waddell G. Low back pain:a twentieth century health care enigma. Spine (Phila Pa 1976) 1996;21:2820-2825.
2. Stokes IA and Iatridis JC. Mechanical conditions that accelerate intervertebral disc degeneration: overload versus immobilization. Spine (Phila Pa 1976) 2004;29:2724-2732.
3. Tschoeke SK, Hellmuth M, Hostmann A, Robinson Y, Ertel W, Oberholzer A and Heyde CE. Apoptosis of human intervertebral discs after trauma compares to degenerated discs involving both receptor-mediated and mitochondrial-dependent pathways. J Orthop Res 2008;26:999-1006.
4. Williams FM, Bansal AT, van Meurs JB, Bell JT, Meulenbelt I, Suri P, Rivadeneira F, Sambrook PN, Hofman A, Bierma-Zeinstra S, Menni C, Kloppenburg M, Slagboom PE, Hunter DJ, Macgregor AJ, Uitterlinden AG and Spector TD. Novel genetic variants associated with lumbar disc degeneration in northern Europeans:a meta-analysis of 4600 subjects. Ann Rheum Dis 2013;72:1141-1148.
5. Sun Z, Zhang M, Zhao XH, Liu ZH, Gao Y, Samartzis D, Wang HQ and Luo ZJ. Immune cascades in human intervertebral disc:the pros and cons. Int J Clin Exp Pathol 2013;6:1009-1014.
6. Wang HQ, Yu XD, Liu ZH, Cheng X, Samartzis D, Jia LT, Wu SX, Huang J, Chen J and Luo ZJ. Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. J Pathol 2011;225:232-242.
7. Hughes SP, Freemont AJ, Hukins DW, McGregor AH and Roberts S. The pathogenesis of degeneration of the intervertebral disc and emerging therapies in the management of back pain. J Bone Joint Surg Br 2012;94:1298-1304.
8. Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MT, Ross ER, O'Brien JP and Hoyland JA. Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol 2002;197:286-292.
9. Mirza SK and White AA 3rd. Anatomy of intervertebral disc and pathophysiology of herniated disc disease. J Clin Laser Med Surg 1995;13:131-142.
10. Fujita N, Imai J, Suzuki T, Yamada M, Ninomiya K, Miyamoto K, Iwasaki R, Morioka H, Matsumoto M, Chiba K, Watanabe S, Suda T, Toyama Y and Miyamoto T. Vascular endothelial growth factor-A is a survival factor for nucleus pulposus cells in the intervertebral disc. Biochem Biophys Res Commun 2008;372:367-372.
11. Salo J, Kaigle Holm A, Indahl A, Mackiewicz Z, Sukura A, Holm S, Jamsen E and Konttinen YT. Expression of vascular endothelial growth factor receptors coincide with blood vessel in-growth and reactive bone remodelling in experimental intervertebral disc degeneration. Clin Exp Rheumatol 2008;26:1018-1026.
12. Tolonen J, Gronblad M, Virri J, Seitsalo S, Rytomaa T and Karaharju EO. Platelet-derived growth factor and vascular endothelial growth factor expression in disc herniation tissue:and immunohistochemical study. Eur Spine J 1997;6:63-69.
13. Lee JM, Song JY, Baek M, Jung HY, Kang H, Han IB, Kwon YD and Shin DE. Interleukin-1beta induces angiogenesis and innervation in human intervertebral disc degeneration. J Orthop Res 2011;29:265-269.
14. Wang J, Markova D, Anderson DG, Zheng Z, Shapiro IM and Risbud MV. TNF-alpha and IL-1beta promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc. J Biol Chem 2011;286:39738-39749.
15. Scholz B, Kinzelmann C, Benz K, Mollenhauer J, Wurst H and Schlosshauer B. Suppression of adverse angiogenesis in an albumin-based hydrogel for articular cartilage and intervertebral disc regeneration. Eur Cell Mater 2010;20:24-36;discussion 36-27.
16. Takada T, Nishida K, Doita M and Kurosaka M. Fas ligand exists on intervertebral disc cells:a potential molecular mechanism for immune privilege of the disc. Spine (Phila Pa 1976) 2002;27:1526-1530.
17. Kaneyama S, Nishida K, Takada T, Suzuki T, Shimomura T, Maeno K, Kurosaka M and Doita M. Fas ligand expression on human nucleus pulposus cells decreases with disc degeneration processes. J Orthop Sci 2008;13:130-135.
18. Depraetere V and Golstein P. Fas and other cell death signaling pathways. Semin Immunol 1997;9:93-107.
19. Liu ZH, Sun Z, Wang HQ, Ge J, Jiang TS, Chen YF, Ma Y, Wang C, Hu S, Samartzis D and Luo ZJ. FasL Expression on Human Nucleus Pulposus Cells Contributes to the Immune Privilege of Intervertebral Disc by Interacting with Immunocytes. Int J Med Sci 2013;10:1053-1060.
20. Sun Z, Wan ZY, Liu ZH, Guo YS, Yin JB, Duan CG, Gao Y, Li T, Wang HQ and Luo ZJ. Expression of soluble Fas and soluble FasL in human nucleus pulposus cells. Int J Clin Exp Pathol 2013;6:1567-1573.
21. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC and Lawley TJ. HMEC-1:establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992;99:683-690.
22. Park JB, Chang H and Kim KW. Expression of Fas ligand and apoptosis of disc cells in herniated lumbar disc tissue. Spine (Phila Pa 1976) 2001;26:618-621.
23. Yamamoto J, Maeno K, Takada T, Kakutani K, Yurube T, Zhang Z, Hirata H, Kurakawa T, Sakai D, Mochida J, Doita M, Kurosaka M and Nishida K. Fas ligand plays an important role for the production of pro-inflammatory cytokines in intervertebral disc nucleus pulposus cells. J Orthop Res 2013;31:608-615.
24. Zhao CQ, Jiang LS and Dai LY. Programmed cell death in intervertebral disc degeneration. Apoptosis 2006;11:2079-2088.
25. Lettau M, Paulsen M, Schmidt H and Janssen O. Insights into the molecular regulation of FasL (CD178) biology. Eur J Cell Biol 2011;90:456-466.
26. Marcelo KL, Goldie LC and Hirschi KK. Regulation of endothelial cell differentiation and specification. Circ Res 2013;112:1272-1287.
27. Chiang JH, Yang JS, Lu CC, Hour MJ, Chang SJ, Lee TH and Chung JG. Newly synthesized quinazolinone HMJ-38 suppresses angiogenetic responses and triggers human umbilical vein endothelial cell apoptosis through p53-modulated Fas/death receptor signaling. Toxicol Appl Pharmacol 2013;269:150-162.
28. Mannam VK, Lewis RE and Cruse JM. The fate of renal allografts hinges on responses of the microvascular endothelium. Exp Mol Pathol 2013;94:398-411.
29. Park JB, Lee JK, Cho ST, Park EY and Riew KD. A biochemical mechanism for resistance of intervertebral discs to metastatic cancer:Fas ligand produced by disc cells induces apoptotic cell death of cancer cells. Eur Spine J 2007;16:1319-1324.
30. Park JB, Lee JK, Park EY and Riew KD. Fas/FasL interaction of nucleus pulposus and cancer cells with the activation of caspases. Int Orthop 2008;32:835-840.
31. Inui Y, Nishida K, Doita M, Takada T, Miyamoto H, Yoshiya S and Kurosaka M. Fas-ligand expression on nucleus pulposus begins in developing embryo. Spine (Phila Pa 1976) 2004;29:2365-2369.
32. Smith LJ and Elliott DM. Formation of lamellar cross bridges in the annulus fibrosus of the intervertebral disc is a consequence of vascular regression. Matrix Biol 2011;30:267-274.
33. Ratsep T, Minajeva A and Asser T. Relationship between neovascularization and degenerative changes in herniated lumbar intervertebral discs. Eur Spine J 2013 Jun 5;[Epub ahead of print].
34. Stefanakis M, Al-Abbasi M, Harding I, Pollintine P, Dolan P, Tarlton J and Adams MA. Annulus fissures are mechanically and chemically conducive to the ingrowth of nerves and blood vessels. Spine (Phila Pa 1976) 2012;37:1883-1891.
35. Melrose J, Roberts S, Smith S, Menage J and Ghosh P. Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration. Spine (Phila Pa 1976) 2002;27:1278-1285.
36. Moon HJ, Kim JH, Lee HS, Chotai S, Kang JD, Suh JK and Park YK. Annulus fibrosus cells interact with neuron-like cells to modulate production of growth factors and cytokines in symptomatic disc degeneration. Spine (Phila Pa 1976) 2012;37:2-9.
37. Johnson WE, Caterson B, Eisenstein SM and Roberts S. Human intervertebral disc aggrecan inhibits endothelial cell adhesion and cell migration in vitro. Spine (Phila Pa 1976) 2005;30:1139-1147.
38. Neidlinger-Wilke C, Liedert A, Wuertz K, Buser Z, Rinkler C, Kafer W, Ignatius A, Claes L, Roberts S and Johnson WE. Mechanical stimulation alters pleiotrophin and aggrecan expression by human intervertebral disc cells and influences their capacity to stimulate endothelial migration. Spine (Phila Pa 1976) 2009;34:663-669.
39. Lidington EA, Moyes DL, McCormack AM and Rose ML. A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transpl Immunol 1999;7:239-246.
40. Han D, Ding Y, Liu SL, Wang G, Si IC, Wang X, Cui L and Huang D. Double role of Fas ligand in the apoptosis of intervertebral disc cells in vitro. Acta Biochim Biophys Sin (Shanghai) 2009;41:938-947.